Abstract |
Tumour resistance to methylating agents is linked to expression of the DNA repair protein O(6)-alkylguanine-DNA alkyltransferase (ATase). There is considerable interest in improving the efficacy of O(6)-alkylating chemotherapy by prior depletion of ATase. We have tested the ability of a modified guanine base, O(6)-(4-bromothenyl)guanine (4BTG), to inactivate ATase and to enhance the anti-tumour effect of temozolomide in an animal model system. A375M human melanoma xenografts were established in the flanks of nude mice. ATase depletion after a single dose of 4BTG or O(6)-BG (20 mg/kg i.p.) was determined over a 24 hr period. Subsequently, we tested the effect of 4BTG (20 mg/kg i.p. daily) and/or temozolomide (80-175 mg/kg i.p. daily) over a 5-day schedule on tumour growth. 4BTG was an effective inactivator of ATase in tumour, producing complete depletion within 2 hr of dosing. Furthermore, it enhanced the tumour growth delay achieved with temozolomide, increasing the tumour quintupling time by 8.7 days (95% confidence interval 6.1-11.3 days, p < 0.0001). Whilst the delay in tumour growth was indistinguishable from that observed with O(6)-benzylguanine (O(6)-BG) and temozolomide, the 4BTG combination resulted in considerably less toxicity (0/9 vs. 2/9 deaths; 6.84% weight loss vs. 9.48%, p = 0.019). 4BTG is a potent inactivator of ATase and enhances the therapeutic ratio of temozolomide in this model system to a greater extent than O(6)-BG.
|
Authors | M R Middleton, J Kelly, N Thatcher, D J Donnelly, R S McElhinney, T B McMurry, J E McCormick, G P Margison |
Journal | International journal of cancer
(Int J Cancer)
Vol. 85
Issue 2
Pg. 248-52
(Jan 15 2000)
ISSN: 0020-7136 [Print] United States |
PMID | 10629085
(Publication Type: Journal Article)
|
Copyright | Copyright 2000 Wiley-Liss, Inc. |
Chemical References |
- Antineoplastic Agents, Alkylating
- Enzyme Inhibitors
- O(6)-(4-bromothenyl)guanine
- O(6)-benzylguanine
- Guanine
- Dacarbazine
- Adenosine Triphosphatases
- Temozolomide
|
Topics |
- Adenosine Triphosphatases
(antagonists & inhibitors, metabolism)
- Animals
- Antineoplastic Agents, Alkylating
(therapeutic use)
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Dacarbazine
(analogs & derivatives, therapeutic use)
- Drug Synergism
- Enzyme Inhibitors
(therapeutic use)
- Guanine
(analogs & derivatives, therapeutic use)
- Male
- Melanoma
(drug therapy, enzymology)
- Mice
- Mice, Nude
- Neoplasm Transplantation
- Temozolomide
- Transplantation, Heterologous
|